Author: Marshall Beck

Screen time associated with behavioural problems in preschoolers

Research from the CHILD Cohort Study suggests that among preschoolers, spending two hours or more of screen time per day may be linked to clinically significant behavioural problems. “We found that screen time had a significant impact on behaviour at

AllerGen’s CEO & CHILD’s Founding Director honoured by CTS

On April 11, 2019, at the annual Canadian Respiratory Conference held in Ottawa, ON, both Dr. Diana Royce, AllerGen’s President and CEO, and AllerGen investigator Dr. Malcolm Sears, the Founding Director of the CHILD Cohort Study, were recognized by the

Filtered diesel exhaust worse for allergy-affected lungs than unfiltered

Diesel exhaust from which tiny particles have been filtered out may be more harmful to the lung function of people with allergies than unfiltered exhaust. This may be due to the fact that some particle-depletion technologies, such as diesel exhaust

CHILD Manitoba co-leaders recognized

Co-leaders of the Manitoba site of the CHILD Cohort Study, AllerGen investigators Drs Allan Becker and Meghan Azad, will be recognized by the University of Manitoba later this month for outstanding accomplishments at their respective career stages. Dr. Becker has

New insights into babies’ first week of development

AllerGen investigators Drs Scott Tebbutt and Tobias Kollman, and AllerGen trainees Casey Shannon, Daniel He and Dr. Amrit Singh, are among the co-authors of a breakthrough study, published in Nature Communications in March 2019, that provides new insight into the

AllerGen begins NCE wind-down

After receiving the full 14 years of national Networks of Centres of Excellence (NCE) funding, today—April 1, 2019—AllerGen begins a two-year wind-down of its NCE mandate. Dr. Judah Denburg, who has led the Network since its planning stages in 2002,

Michelle Harkness Mentorship Awards celebrate & promote mentoring excellence

On the evening of January 29, 2019, at the Gala event of AllerGen’s final Research Conference, eight exceptional members of the AllerGen network were recognized for their excellence as mentors, and four others were awarded grants to support the development

AllerGen investigators lead two platforms of new pan-Canadian microbiome research core

The CIHR is funding a new, national microbiome research core, and two of its five platforms are headed by AllerGen investigators. The University of Calgary-based initiative, The Integrated Microbiome Platforms for Advancing Causation Testing and Translation, or IMPACTT, brings together

AllerGen’s final research conference… and beyond

Marking the culmination of 14 years of research, AllerGen held its ninth and final Research Conference from January 27-30, 2019, in Toronto, ON. Over 220 delegates participated. Nearly half were AllerGen trainees, some of whom have been involved in the

Infant sleep duration associated with mother’s level of education, prenatal depression and method of delivery

New research from AllerGen’s CHILD Cohort Study has found that babies sleep less at three months of age if their mothers do not have a university degree, experienced depression during pregnancy or had an emergency cesarean-section delivery. “Sleep affects a

Allergic reactions frequent in children undergoing milk oral immunotherapy

Oral immunotherapy (OIT) is a relatively new approach to treating food allergies that exposes allergic patients to gradually increased doses of an allergenic food to desensitize their immune systems. While OIT can be safely used to treat the majority of

Dr. Moshe Ben-Shoshan funded to study children’s allergies to antibiotics

AllerGen investigator Dr. Moshe Ben-Shoshan (Montreal Children’s Hospital) has been awarded a four-year, $336,000 CIHR Project Grant to explore adverse reactions to antibiotics among children. His project aims to determine how often these adverse reactions—typically seen in the form of

Top